Quantum Cyber N.V. Interest Expense
Quantum Cyber N.V. (QUCY) reported Interest Expense of $201.95 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2025-09-26
- Quantum Cyber N.V. interest expense for the quarter ending 2023-12-31 was $441.71K.
- Quantum Cyber N.V. interest expense for the quarter ending 2023-09-30 was -$8.07K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-06-30 | $201.95K 6-K · filed 2025-09-26 | |||||
| 2024-12-31 | $1.05M 20-F · filed 2025-03-31 | |||||
| 2024-06-30 | $646.44K 6-K · filed 2025-09-26 | $659.47K 6-K · filed 2024-10-18 | ||||
| 2023-12-31 | $441.71K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $433.64K derived: sum of 2 quarters · filed 2025-03-31 | $522.40K 20-F · filed 2025-03-31 | $559.58K 20-F · filed 2024-04-09 | ||
| 2023-09-30 | -$8.07K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $80.69K 6-K · filed 2023-11-16 | ||||
| 2023-06-30 | $88.76K 6-K · filed 2024-10-18 | $51.35K 6-K · filed 2023-08-15 | ||||
| 2022-12-31 | $242.02K 20-F · filed 2025-03-31 | $209.70K 20-F · filed 2023-04-07 | ||||
| 2022-06-30 | $75.22K 6-K · filed 2022-09-07 | |||||
| 2021-12-31 | $339.17K 20-F · filed 2024-04-09 | $199.20K 20-F · filed 2022-05-03 | ||||
| 2021-06-30 | $73.36K 6-K · filed 2022-09-07 | |||||
| 2020-12-31 | $176.42K 20-F · filed 2023-04-07 | |||||
| 2019-12-31 | $156.87K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |